359 related articles for article (PubMed ID: 25232085)
1. Allogenic blood transfusion following total hip arthroplasty: results from the nationwide inpatient sample, 2000 to 2009.
Saleh A; Small T; Chandran Pillai AL; Schiltz NK; Klika AK; Barsoum WK
J Bone Joint Surg Am; 2014 Sep; 96(18):e155. PubMed ID: 25232085
[TBL] [Abstract][Full Text] [Related]
2. An analysis of blood management in patients having a total hip or knee arthroplasty.
Bierbaum BE; Callaghan JJ; Galante JO; Rubash HE; Tooms RE; Welch RB
J Bone Joint Surg Am; 1999 Jan; 81(1):2-10. PubMed ID: 9973048
[TBL] [Abstract][Full Text] [Related]
3. Decline in allogeneic blood transfusion usage in total hip arthroplasty patients: National Inpatient Sample 2009 to 2013.
Gwam CU; Mistry JB; Etcheson JI; George NE; Connors G; Thomas M; Adamu H; Patel NG; Delanois RE
Hip Int; 2018 Jul; 28(4):382-390. PubMed ID: 29218687
[TBL] [Abstract][Full Text] [Related]
4. Transfusion rates are increasing following total hip arthroplasty: risk factors and outcomes.
Browne JA; Adib F; Brown TE; Novicoff WM
J Arthroplasty; 2013 Sep; 28(8 Suppl):34-7. PubMed ID: 23896359
[TBL] [Abstract][Full Text] [Related]
5. Are Allogeneic Transfusions Decreasing in Total Knee Arthroplasty Patients? National Inpatient Sample 2009-2013.
Mistry JB; Gwam CU; Naziri Q; Pivec R; Abraham R; Mont MA; Delanois RE
J Arthroplasty; 2018 Jun; 33(6):1705-1712. PubMed ID: 29352682
[TBL] [Abstract][Full Text] [Related]
6. Predictors of perioperative blood loss in total joint arthroplasty.
Park JH; Rasouli MR; Mortazavi SM; Tokarski AT; Maltenfort MG; Parvizi J
J Bone Joint Surg Am; 2013 Oct; 95(19):1777-83. PubMed ID: 24088970
[TBL] [Abstract][Full Text] [Related]
7. Use of a bipolar sealer in total hip arthroplasty: medical resource use and costs using a hospital administrative database.
Ackerman SJ; Tapia CI; Baik R; Pivec R; Mont MA
Orthopedics; 2014 May; 37(5):e472-81. PubMed ID: 24810825
[TBL] [Abstract][Full Text] [Related]
8. The Frank Stinchfield Award : Total Hip Arthroplasty for Femoral Neck Fracture Is Not a Typical DRG 470: A Propensity-matched Cohort Study.
Schairer WW; Lane JM; Halsey DA; Iorio R; Padgett DE; McLawhorn AS
Clin Orthop Relat Res; 2017 Feb; 475(2):353-360. PubMed ID: 27154530
[TBL] [Abstract][Full Text] [Related]
9. Smoking and Total Hip Arthroplasty: Increased Inpatient Complications, Costs, and Length of Stay.
Debbi EM; Rajaee SS; Spitzer AI; Paiement GD
J Arthroplasty; 2019 Aug; 34(8):1736-1739. PubMed ID: 31027857
[TBL] [Abstract][Full Text] [Related]
10. Does Hemophilia Increase Risk of Adverse Outcomes Following Total Hip and Knee Arthroplasty? A Propensity Score-Matched Analysis of a Nationwide, Population-Based Study.
Wang SH; Chung CH; Chen YC; Cooper AM; Chien WC; Pan RY
J Arthroplasty; 2019 Oct; 34(10):2329-2336.e1. PubMed ID: 31337553
[TBL] [Abstract][Full Text] [Related]
11. Primary total knee arthroplasty allogenic transfusion trends, length of stay, and complications: nationwide inpatient sample 2000-2009.
Klika AK; Small TJ; Saleh A; Szubski CR; Chandran Pillai AL; Barsoum WK
J Arthroplasty; 2014 Nov; 29(11):2070-7. PubMed ID: 25073900
[TBL] [Abstract][Full Text] [Related]
12. The Impact of Solid Organ Transplant History on Inpatient Complications, Mortality, Length of Stay, and Cost for Primary Total Hip Arthroplasty Admissions in the United States.
Navale SM; Szubski CR; Klika AK; Schiltz NK; Desai PP; Barsoum WK
J Arthroplasty; 2017 Apr; 32(4):1107-1116.e1. PubMed ID: 27913128
[TBL] [Abstract][Full Text] [Related]
13. Alternative Payment Models Should Risk-Adjust for Conversion Total Hip Arthroplasty: A Propensity Score-Matched Study.
McLawhorn AS; Schairer WW; Schwarzkopf R; Halsey DA; Iorio R; Padgett DE
J Arthroplasty; 2018 Jul; 33(7):2025-2030. PubMed ID: 29275113
[TBL] [Abstract][Full Text] [Related]
14. Incidence and risk factors for allogenic blood transfusion during major joint replacement using an integrated autotransfusion regimen. The Rizzoli Study Group on Orthopaedic Anaesthesia.
Borghi B; Casati A
Eur J Anaesthesiol; 2000 Jul; 17(7):411-7. PubMed ID: 10964142
[TBL] [Abstract][Full Text] [Related]
15. [Local Application of Tranexamic Acid in Total Hip Arthroplasty Decreases Blood Loss and Consumption of Blood Transfusion].
Lošťák J; Gallo J; Večeřa M; Špička J; Langová K
Acta Chir Orthop Traumatol Cech; 2017; 84(4):254-262. PubMed ID: 28933328
[TBL] [Abstract][Full Text] [Related]
16. Does Parkinson Disease Increase the Risk of Perioperative Complications After Total Hip Arthroplasty? A Nationwide Database Study.
Newman JM; Sodhi N; Dalton SE; Khlopas A; Newman RP; Higuera CA; Mont MA
J Arthroplasty; 2018 Jul; 33(7S):S162-S166. PubMed ID: 29402715
[TBL] [Abstract][Full Text] [Related]
17. Perioperative blood management programme reduces the use of allogenic blood transfusion in patients undergoing total hip and knee arthroplasty.
Kopanidis P; Hardidge A; McNicol L; Tay S; McCall P; Weinberg L
J Orthop Surg Res; 2016 Feb; 11():28. PubMed ID: 26927608
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for infection, revision, death, blood transfusion and longer hospital stay 3 months and 1 year after primary total hip or knee arthroplasty.
Rhee C; Lethbridge L; Richardson G; Dunbar M
Can J Surg; 2018 Jun; 61(3):165-176. PubMed ID: 29806814
[TBL] [Abstract][Full Text] [Related]
19. Medicaid payer status is associated with in-hospital morbidity and resource utilization following primary total joint arthroplasty.
Browne JA; Novicoff WM; D'Apuzzo MR
J Bone Joint Surg Am; 2014 Nov; 96(21):e180. PubMed ID: 25378513
[TBL] [Abstract][Full Text] [Related]
20. Postoperative autologous blood salvage drains--are they useful in primary uncemented hip and knee arthroplasty? A prospective study of 186 cases.
Jones HW; Savage L; White C; Goddard R; Lumley H; Kashif F; Gurusany K
Acta Orthop Belg; 2004 Oct; 70(5):466-73. PubMed ID: 15587036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
